Logistical challenges for potential SARS-CoV-2 vaccine and a call to research institutions, developers and manufacturers.

Kartoglu, Umit H; Moore, Kelly L; Lloyd, John S

Kartoglu, Umit H; Moore, Kelly L; Lloyd, John S.

Kartoglu UH; Extensio et Progressio, 1A Chemin du Pre-d'Orsat, 1245 Collonge-Bellerive, Switzerland. Electronic address: umit@kartoglu.ch.
Moore KL; Immunization Action Coalition, Saint-Paul, MN, United States; Vanderbilt School of Medicine, TN, United States. Electronic address: Kelly.moore@immunize.org.
Lloyd JS; Independent consultant, Tournus, France. Electronic address: john.lloyd1945@gmail.com.

Vaccine ; 38(34): 5393-5395, 2020 07 22.

Article in English | MEDLINE | ID: covidwho-611224

Subject(s)

Biomedical Research/organization & administration; Drug Industry/organization & administration; International Cooperation; Viral Vaccines/supply & distribution; COVID-19; COVID-19 Vaccines; Coronavirus Infections/prevention & control; Humans; Pandemics/prevention & control; Pneumonia, Viral/prevention & control; World Health Organization/organization & administration

Keywords

SARS-CoV-2; VVM; Vaccine logistics; Vaccine target profile; Vaccine vial monitor

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Viral Vaccines / Biomedical Research / Drug Industry / International Cooperation Topics: Vaccines Limits: Humans Language: English Journal: Vaccine Year: 2020 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google